Finzati - Logo
BUSE logo

First Busey Corporation

BUSEBanks - Regional
$0.00
0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$2.63B
Growth
2.8%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 13.0%Positive revenue growth · 10.7%Positive free cash flow · 1.95Consistent free cash flow · 5/5Reasonable earnings multiple · 15.68
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:56 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$2.63B
52W Range21.96 - 31.70
Beta0.71
Gross Margin63.88%
Oper. Margin17.88%
Profit Margin12.96%
Debt/Eq0.20
Current Ratio0.07
Quick Ratio0.07
Revenue 5Y2.80%

Investment DNA

How strong this company looks for long-term investors

70
out of 100
Business Quality
Margins, moat, returns
65/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score
Stable or improving margins · 13.0%Positive revenue growth · 10.7%Positive free cash flow · 1.95Consistent free cash flow · 5/5Reasonable earnings multiple · 15.68Manageable debt level · 0.2

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$28.00
Mean
$31.50
Median
$31.50
High
$35.00

Company Overview

IPO: 10/6/1998
Industry: Banks - Regional
P/B i: 0.86
Debt / Equity i: 0.20
Operating Margin: 17.88%
Net Margin: 12.96%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 0.20
Current Ratio: 0.07
Quick Ratio: 0.07
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Brenneman Rod
Transaction: 07/31/2026
BUY
Change
+53
Price
Not reported
Filing
08/04/2026
Type
BUY
CAPLE STEVEN W
Transaction: 07/31/2026
BUY
Change
+53
Price
Not reported
Filing
08/04/2026
Type
BUY
Cassens Michael David
Transaction: 07/31/2026
BUY
Change
+221
Price
Not reported
Filing
08/04/2026
Type
BUY